Tacrolimus and Azole Derivatives of Agricultural and Human Health Importance: Prediction of ADME Properties

References

1. BergerS. El ChazliY. BabuA.F. CosteA.T. Azole resistance in aspergillus fumigatus: a consequence of antifungal use in agriculture?Front. Microbiol.20178102410.3389/fmicb.2017.0102428638374
   [Google Scholar]
2. AntypenkoL. MeyerF. SadykovaZ. ShabelnykK. KovalenkoS. SteffensK.G. GarbeL-A. Combined application of tacrolimus with cyproconazole, hymexazol and novel {2-(3-R-1H-1,2,4-triazol-5-yl)phenyl}amines as antifungals: in vitro growth inhibition and in silico molecular docking analysis to fungal chitin deacetylase.J. Fungi2023917910.3390/jof901007936675900
   [Google Scholar]
3. LiuY. AhmedS. FangY. ChenM. AnJ. YangG. HouX. LuJ. YeQ. ZhuR. LiuQ. LiuS. Discovery of chitin deacetylase inhibitors through structure-based virtual screening and biological assays.J. Microbiol. Biotechnol.202232450451310.4014/jmb.2201.0100935131956
   [Google Scholar]
4. CedergreenN. Quantifying synergy: a systematic review of mixture toxicity studies within environmental toxicology.PLoS One201495e9658010.1371/journal.pone.009658024794244
   [Google Scholar]
5. SwissADMESwiss Institute of Bioinformatics.2022Available from: http://www.swissadme.ch/index.php#
   [Google Scholar]
6. DainaA. MichielinO. ZoeteV. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules.Sci. Rep.2017714271710.1038/srep4271728256516
   [Google Scholar]
7. LipinskiC.A. LombardoF. DominyB.W. FeeneyP.J. Experimental and computational approaches to estimate solubilityand permeability in drug discovery and development settings.Adv. Drug Deliv. Rev.2001461-332610.1016/S0169‑409X(00)00129‑011259830
   [Google Scholar]
8. GhoseA.K. ViswanadhanV.N. WendoloskiJ.J. A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of known drug databases.J. Comb. Chem.199911556810.1021/cc980007110746014
   [Google Scholar]
9. VeberD.F. JohnsonS.R. ChengH.Y. SmithB.R. WardK.W. KoppleK.D. Molecular properties that influence the oral bioavailability of drug candidates.J. Med. Chem.200245122615262310.1021/jm020017n12036371
   [Google Scholar]
10. EganW.J. MerzK.M.Jr BaldwinJ.J. Prediction of drug absorption using multivariate statistics.J. Med. Chem.200043213867387710.1021/jm000292e11052792
    [Google Scholar]
11. MueggeI. HealdS.L. BrittelliD. Simple selection criteria for drug-like chemical matter.J. Med. Chem.200144121841184610.1021/jm015507e11384230
    [Google Scholar]
12. MartinY.C. A bioavailability score.J. Med. Chem.20054893164317010.1021/jm049200215857122
    [Google Scholar]
13. LoveringF. BikkerJ. HumbletC. Escape from flatland: increasing saturation as an approach to improving clinical success.J. Med. Chem.200952216752675610.1021/jm901241e19827778
    [Google Scholar]
14. LeeM.S. FeigM. SalsburyF.R.Jr BrooksC.L. III New analytic approximation to the standard molecular volume definition and its application to generalized Born calculations.J. Comput. Chem.200324111348135610.1002/jcc.1027212827676
    [Google Scholar]
15. DainaA. MichielinO. ZoeteV. iLOGP: a simple, robust, and efficient description of n-octanol/water partition coefficient for drug design using the GB/SA approach.J. Chem. Inf. Model.201454123284330110.1021/ci500467k25382374
    [Google Scholar]
16. MoriguchiI. HironoS. LiuQ. NakagomeI. MatsushitaY. Simple method of calculating octanol/water partition coefficient.Chem. Pharm. Bull.199240112713010.1248/cpb.40.127
    [Google Scholar]
17. ChengT. ZhaoY. LiX. LinF. XuY. ZhangX. LiY. WangR. LaiL. Computation of octanol-water partition coefficients by guiding an additive model with knowledge.J. Chem. Inf. Model.20074762140214810.1021/ci700257y17985865
    [Google Scholar]
18. DelaneyJ.S. ESOL: estimating aqueous solubility directly from molecular structure.J. Chem. Inf. Comput. Sci.20044431000100510.1021/ci034243x15154768
    [Google Scholar]
19. AliJ. CamilleriP. BrownM.B. HuttA.J. KirtonS.B. Revisiting the general solubility equation: in silico prediction of aqueous solubility incorporating the effect of topographical polar surface area.J. Chem. Inf. Model.201252242042810.1021/ci200387c22196228
    [Google Scholar]
20. ZhangA.Y. CampW.L. ElewskiB.E. Advances in topical and systemic antifungals.Dermatol. Clin.2007252165183vi.10.1016/j.det.2007.01.00217430754
    [Google Scholar]
21. KaurI.P. KakkarS. Topical delivery of antifungal agents.Expert Opin. Drug Deliv.20107111303132710.1517/17425247.2010.52523020961206
    [Google Scholar]
22. GűngőrS. ErdalM.S. AksuB. New formulation strategies in topical antifungal therapy.J. Cosm. Dermatol. Sci. Appl201335665
    [Google Scholar]
23. RitchieT.J. ErtlP. LewisR. The graphical representation of ADME-related molecule properties for medicinal chemists.Drug Discov. Today2011161-2657210.1016/j.drudis.2010.11.00221074634
    [Google Scholar]
24. PottsR.O. GuyR.H. Predicting skin permeability.Pharm. Res.19929566366910.1023/A:10158103124651608900
    [Google Scholar]
25. MontanariF. EckerG.F. Prediction of drug–ABC-transporter interaction-recent advances and future challenges.Adv. Drug Deliv. Rev.201586172610.1016/j.addr.2015.03.00125769815
    [Google Scholar]
26. SzakácsG. VáradiA. Özvegy-LaczkaC. SarkadiB. The role of ABC transporters in drug absorption, distribution, metabolism, excretion and toxicity (ADME–Tox).Drug Discov. Today2008139-1037939310.1016/j.drudis.2007.12.01018468555
    [Google Scholar]
27. SaadA.H. DePestelD.D. CarverP.L. Factors influencing the magnitude and clinical significance of drug interactions between azole antifungals and select immunosuppressants.Pharmacotherapy200626121730174410.1592/phco.26.12.173017125435
    [Google Scholar]
28. TaviraB. GómezJ. Díaz-CorteC. CoronelD. Lopez-LarreaC. SuarezB. CotoE. The donor ABCB1 (MDR-1) C3435T polymorphism is a determinant of the graft glomerular filtration rate among tacrolimus treated kidney transplanted patients.J. Hum. Genet.201560527327610.1038/jhg.2015.1225673014
    [Google Scholar]
29. Piletta-ZaninA. De MulA. RockN. LescuyerP. SamerC.F. RodieuxF. Case Report: Low hematocrit leading to tacrolimus toxicity.Front. Pharmacol.20211271714810.3389/fphar.2021.71714834483924
    [Google Scholar]
30. DiL. The role of drug metabolizing enzymes in clearance.Expert Opin. Drug Metab. Toxicol.201410337939310.1517/17425255.2014.87600624392841
    [Google Scholar]
31. Oral toxicity prediction results for input compound.2022Available from: https://tox-new.charite.de/protox_II/index.php?site=compound_input
32. BaellJ.B. HollowayG.A. New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays.J. Med. Chem.20105372719274010.1021/jm901137j20131845
    [Google Scholar]
33. BrenkR. SchipaniA. JamesD. KrasowskiA. GilbertI.H. FrearsonJ. WyattP.G. Lessons learnt from assembling screening libraries for drug discovery for neglected diseases.ChemMedChem20083343544410.1002/cmdc.20070013918064617
    [Google Scholar]
34. DainaA. ZoeteV. A BOILED-Egg to predict gastrointestinal absorption and brain penetration of small molecules.ChemMedChem201611111117112110.1002/cmdc.20160018227218427
    [Google Scholar]